Bandaram Pharma Packtech Intrinsic Value
Bandaram Pharma Packtech intrinsic value. Bandaram Pharma Packtech (BANDARAM) median intrinsic value is ₹8.80 from 7 valuation models (range ₹6–₹38), vs current price ₹19.09 — -53.9% downside (Trading Above Calculated Value), margin of safety -100.0%. Compare with BANDARAM DCF valuation to assess whether the stock is under or overvalued.
BANDARAM Valuation Methods Summary — DCF, Graham Number & P/E
Bandaram Pharma Packtech intrinsic value across 7 models vs current price ₹19.09 — upside/downside and value range per method. Read BANDARAM dividend track record for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹5.73 | ₹4.58 - ₹6.88 | -70.0% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹17.22 | ₹15.50 - ₹18.94 | -9.8% | Book Value/Share: ₹17.22, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹38.18 | ₹34.36 - ₹42.00 | +100.0% | Revenue/Share: ₹57.78, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹13.33 | ₹12.00 - ₹14.66 | -30.2% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹5.73 | ₹5.16 - ₹6.30 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹5.73 | ₹5.16 - ₹6.30 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹8.80 | ₹7.92 - ₹9.68 | -53.9% | EPS: ₹0.20, BVPS: ₹17.22 |
BANDARAM Intrinsic Value vs Market Price — All Valuation Models
Bandaram Pharma Packtech fair value range ₹6–₹38 vs current market price ₹19.09 across 7 valuation models. For current market price and key ratios, visit BANDARAM stock price BSE.
BANDARAM Intrinsic Value Analysis — Undervalued or Overvalued?
Bandaram Pharma Packtech median intrinsic value ₹8.80, current price ₹19.09 — Trading Above Calculated Value by 53.9%, margin of safety -100.0%.
What is the intrinsic value of BANDARAM?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Bandaram Pharma Packtech (BANDARAM) is ₹8.80 (median value). With the current market price of ₹19.09, this represents a -53.9% variance from our estimated fair value.
The valuation range spans from ₹5.73 to ₹38.18, indicating ₹5.73 - ₹38.18.
Is BANDARAM undervalued or overvalued?
Based on our multi-method analysis, Bandaram Pharma Packtech (BANDARAM) appears to be trading above calculated value by approximately 53.9%.
BANDARAM Financial Health — Key Ratios vs Industry Benchmarks
Bandaram Pharma Packtech financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.70 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.37x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
BANDARAM Cash Flow Quality — Operating & Free Cash Flow
Bandaram Pharma Packtech operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-4 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-1 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |